# Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

> **NCT00857220** · PHASE3 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 304 (actual)

## Conditions studied

- Insomnia
- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** eszopiclone
- **DRUG:** eszopiclone

## Key facts

- **NCT ID:** NCT00857220
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00857220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00857220, "Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00857220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*